Multicell Techs Stock Fundamentals
Multicell Techs fundamentals help investors to digest information that contributes to Multicell Techs' financial success or failures. It also enables traders to predict the movement of Multicell Pink Sheet. The fundamental analysis module provides a way to measure Multicell Techs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Multicell Techs pink sheet.
Multicell |
Multicell Techs Company Profit Margin Analysis
Multicell Techs' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Multicell Techs Profit Margin | (0.31) % |
Most of Multicell Techs' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Multicell Techs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Multicell Techs has a Profit Margin of -0.3149%. This is 97.19% lower than that of the Biotechnology sector and 98.63% lower than that of the Health Care industry. The profit margin for all United States stocks is 75.2% lower than that of the firm.
Multicell Techs Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Multicell Techs's current stock value. Our valuation model uses many indicators to compare Multicell Techs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Multicell Techs competition to find correlations between indicators driving Multicell Techs's intrinsic value. More Info.Multicell Techs is rated below average in return on asset category among its peers. It is considered to be number one stock in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Multicell Techs' earnings, one of the primary drivers of an investment's value.Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Multicell Fundamentals
| Return On Asset | -1.36 | |||
| Profit Margin | (0.31) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | 1.22 M | |||
| Shares Outstanding | 5 B | |||
| Shares Owned By Insiders | 9.90 % | |||
| Price To Sales | 0.01 X | |||
| Revenue | 49.32 K | |||
| Gross Profit | 49.32 K | |||
| Net Income | (380.07 K) | |||
| Cash And Equivalents | 281.12 K | |||
| Total Debt | 36.43 K | |||
| Current Ratio | 0.19 X | |||
| Cash Flow From Operations | (1.09 M) | |||
| Beta | -7.77 | |||
| Market Capitalization | 1 M | |||
| Total Asset | 126.22 K | |||
| Retained Earnings | (50.74 M) | |||
| Working Capital | (1.24 M) | |||
| Current Asset | 295 K | |||
| Current Liabilities | 1.54 M | |||
| Net Asset | 126.22 K |
About Multicell Techs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Multicell Techs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Multicell Techs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Multicell Techs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island. Multicell Techs operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Multicell Pink Sheet Analysis
When running Multicell Techs' price analysis, check to measure Multicell Techs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Multicell Techs is operating at the current time. Most of Multicell Techs' value examination focuses on studying past and present price action to predict the probability of Multicell Techs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Multicell Techs' price. Additionally, you may evaluate how the addition of Multicell Techs to your portfolios can decrease your overall portfolio volatility.